Romosozumab
Also known as: sclerostin antibody, EVENITY research
Anti-sclerostin biologic that increases bone formation while decreasing resorption; studied in bone density research.
Quick Reference
Romosozumab - Research Images
PSO vial render · Scientific images from Wikipedia · Tap to enlarge
Overview
Pharmaceutical drug
Romosozumab, sold under the brand name Evenity, is a medication used to treat osteoporosis. It has been found to decrease the risk of fractures of the spine.
Mechanism of Action
Romosozumab, sold under the brand name Evenity, is a medication used to treat osteoporosis. It has been found to decrease the risk of fractures of the spine.
What Researchers Are Saying
Community Reports - Not Medical Advice
The following is aggregated from public forums, Reddit, and research communities. These are anecdotal reports from researchers only - not verified clinical data and not a recommendation of any kind.
Romosozumab (also known as sclerostin antibody, EVENITY research) is studied within the peptide research community. Anti-sclerostin biologic that increases bone formation while decreasing resorption; studied in bone density research.
Last updated October 28, 2026
Research status: emerging. Romosozumab appears across peptide research forums and academic literature. Researchers note this compound falls in the other category.
Last updated October 28, 2026
What Do You Think of This Peptide?
Share your opinion or research experience with Romosozumab. Comments are reviewed before appearing.